These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19701985)

  • 21. Trial finds simultaneous HIV/tuberculosis treatment beneficial.
    Baleta A
    Lancet Infect Dis; 2008 Nov; 8(11):669. PubMed ID: 18992400
    [No Abstract]   [Full Text] [Related]  

  • 22. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral therapy and the prevalence and incidence of diabetes.
    Mikhail N; Cope D
    Arch Intern Med; 2005 Nov; 165(21):2536-7; author reply 2537. PubMed ID: 16314552
    [No Abstract]   [Full Text] [Related]  

  • 24. Median Time to Antiretroviral Therapy Initiation in a Cohort of Chinese Infants Born With HIV.
    Zhao Y; Wang Y; Wang A; McGoogan JM; Wu Z
    JAMA Pediatr; 2018 Jan; 172(1):90-92. PubMed ID: 29131885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe bruising in an HIV-positive patient with haemophilia after using a needle-free gas-powered injection device.
    Yoong D; Loufty M; Chin T; Bayoumi AM
    AIDS; 2007 Jul; 21(11):1499-500. PubMed ID: 17589206
    [No Abstract]   [Full Text] [Related]  

  • 26. Optimum time to initiate antiretroviral therapy in patients with HIV-associated tuberculosis: there may be more than one right answer.
    Lawn SD; Wood R
    J Acquir Immune Defic Syndr; 2007 Sep; 46(1):121-3; author reply 123. PubMed ID: 17909319
    [No Abstract]   [Full Text] [Related]  

  • 27. Serious non-AIDS conditions: redefining the spectrum of HIV-related disease.
    Baker J; Henry K
    AIDS Clin Care; 2007 Sep; 19(9):73-4, 80. PubMed ID: 18398992
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV survival benefit associated with earlier antiviral therapy.
    Mocroft A; Phillips AN; Lundgren JD
    Ann Intern Med; 2004 Apr; 140(7):578-9; author reply 579. PubMed ID: 15068990
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effectiveness of strategies for monitoring the response to antiretroviral therapy in resource-limited settings.
    Phillips AN; Gilks C; Lundgren JD
    Arch Intern Med; 2009 May; 169(9):904; author reply 904-5. PubMed ID: 19433706
    [No Abstract]   [Full Text] [Related]  

  • 30. [Optimal time for antiretroviral therapy of HIV infection: NA-ACCORD (North American AIDS cohort collaboration on research and design)].
    Jensen B; Nitschmann S; Häussinger D
    Internist (Berl); 2009 Dec; 50(12):1425-6. PubMed ID: 19902153
    [No Abstract]   [Full Text] [Related]  

  • 31. Shooting at a moving target: natural history studies and the rapidly improving state of anti-HIV treatment.
    McKinney RE
    J Pediatr; 2002 Sep; 141(3):301-2. PubMed ID: 12219046
    [No Abstract]   [Full Text] [Related]  

  • 32. 2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
    Bucher HC; Wolbers M; Porter K
    JAMA; 2010 Nov; 304(17):1897; author reply 1897-8. PubMed ID: 21045094
    [No Abstract]   [Full Text] [Related]  

  • 33. Causes of death shift over time.
    TreatmentUpdate; 2001; 12(12):15-6. PubMed ID: 11570083
    [No Abstract]   [Full Text] [Related]  

  • 34. [Can antiretroviral treatment eradicate Prurigo nodularis in HIV infected patients?].
    Ouattara I; Eholié SP; Aoussi E; Bissagnéne E; Raffi F
    Med Mal Infect; 2009 Jun; 39(6):415-6. PubMed ID: 19423251
    [No Abstract]   [Full Text] [Related]  

  • 35. QT interval prolongation and antiretroviral treatment: another point of interest.
    Chinello P; Petrosillo N
    Clin Infect Dis; 2007 May; 44(10):1388-9; author reply 1389-91. PubMed ID: 17443482
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiretroviral therapy increases risk of heart attack.
    Gottlieb S
    BMJ; 2003 Nov; 327(7425):1186. PubMed ID: 14630739
    [No Abstract]   [Full Text] [Related]  

  • 37. [Yes, simplify antiretroviral treatments, but not at a significant price!].
    Casalino E
    Med Mal Infect; 2005 Apr; 35 Suppl 1():S11-4. PubMed ID: 15922875
    [No Abstract]   [Full Text] [Related]  

  • 38. [What happens when antiretroviral treatment is interrupted in clinical practice?].
    Marcos Sánchez F; Albo Castaño I; Joya Seijo D; del Valle Loarte P; Martín Barranco MJ
    An Med Interna; 2005 Oct; 22(10):502. PubMed ID: 16411308
    [No Abstract]   [Full Text] [Related]  

  • 39. The future of HIV vasculopathy when our patients are on antiretroviral therapy.
    Barry R
    S Afr J Surg; 2009 May; 47(2):58, 60. PubMed ID: 19626782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. African trial of HIV drug disappoints.
    AIDS Read; 2008 Apr; 18(4):166. PubMed ID: 18467998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.